Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

PKHB1, a thrombospondin-1 peptide mimic, induces anti-tumor effect through immunogenic cell death induction in breast cancer cells
Kenny Misael Calvillo‐Rodríguez, Rodolfo Mendoza-Reveles, Luis Gómez‐Morales, et al.
OncoImmunology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Research progress in inducing immunogenic cell death of tumor cells
Deqian Xie, Qifei Wang, Guangzhen Wu
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 38
HMGB1 in the interplay between autophagy and apoptosis in cancer
Ruochan Chen, Zou Ju, Xiao Yan Zhong, et al.
Cancer Letters (2023) Vol. 581, pp. 216494-216494
Closed Access | Times Cited: 26
Bioactive Peptide Nanodrugs Based on Supramolecular Assembly for Boosting Immunogenic Cell Death‐Induced Cancer Immunotherapy
Yamei Liu, Rui Chang, Ruirui Xing, et al.
Small Methods (2023) Vol. 7, Iss. 5
Closed Access | Times Cited: 25
Immunogenic cell death inducer peptides: A new approach for cancer therapy, current status and future perspectives
Hamid Aria, Marzieh Rezaei
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114503-114503
Open Access | Times Cited: 25
Argon gas plasma-treated physiological solutions stimulate immunogenic cell death and eradicates immunosuppressive CD47 protein in lung carcinoma
Manorma Negi, Neha Kaushik, Linh Nhat Nguyen, et al.
Free Radical Biology and Medicine (2023) Vol. 201, pp. 26-40
Closed Access | Times Cited: 19
Immunotherapies inducing immunogenic cell death in cancer: insight of the innate immune system
Kenny Misael Calvillo‐Rodríguez, Helen Yarimet Lorenzo-Anota, Cristina Rodríguez‐Padilla, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 18
Counter regulation of tumor angiogenesis by vascular endothelial growth factor and thrombospondin-1
Jack Lawler
Seminars in Cancer Biology (2022) Vol. 86, pp. 126-135
Closed Access | Times Cited: 21
A novel thrombospondin-1 variant as a potential diagnostic biomarker and therapeutic target in canine mammary tumor and osteosarcoma cells
Yukyung Hong, Heyeon Baik, Jeong-Min Lee, et al.
Journal of Veterinary Science (2025) Vol. 26
Open Access
An enzyme-activated and structural transformable supramolecular oncolytic peptide for efficient cancer immunotherapy through systemic administration
H. H. Zhang, Xingjie Hu, Yuhan Hu, et al.
Nano Today (2025) Vol. 62, pp. 102699-102699
Closed Access
Calreticulin as a marker and therapeutic target for cancer
Meilan Zhang, Juan Xiao, Jiangrong Liu, et al.
Clinical and Experimental Medicine (2022) Vol. 23, Iss. 5, pp. 1393-1404
Closed Access | Times Cited: 16
A combination of genetically engineered oncolytic virus and melittin-CpG for cancer viro-chemo-immunotherapy
Amirhossein Bahreyni, Huitao Liu, Yasir Mohamud, et al.
BMC Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 10
Thrombospondins in the tumor microenvironment
Jim Petrik, Sylvia Lauks, Bianca Garlisi, et al.
Seminars in Cell and Developmental Biology (2023) Vol. 155, pp. 3-11
Closed Access | Times Cited: 10
Afzelin induces immunogenic cell death against lung cancer by targeting NQO2
Lei Xia, Xiaoqing Xu, Meijun Li, et al.
BMC Complementary Medicine and Therapies (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 10
Dendritic Cells Pulsed with Tumor Lysates Induced by Tetracyanotetra(aryl)porphyrazines-Based Photodynamic Therapy Effectively Trigger Anti-Tumor Immunity in an Orthotopic Mouse Glioma Model
Tikhon S. Redkin, Ekaterina E. Sleptsova, Victoria D. Turubanova, et al.
Pharmaceutics (2023) Vol. 15, Iss. 10, pp. 2430-2430
Open Access | Times Cited: 8
Recent advances and applications of peptide–agent conjugates for targeting tumor cells
Vahab Alamdari-Palangi, Khojaste Rahimi Jaberi, Mahshid Shahverdi, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 16, pp. 15249-15273
Closed Access | Times Cited: 7
PKHB1 peptide induces antiviral effects through induction of immunogenic cell death in herpes simplex keratitis
Yun He, Chenchen Wang, Qi Liang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 10
Thrombospondin‐1 mimic peptide PKHB1 induced endoplasmic reticulum stress‐mediated but CD47‐independent apoptosis in non‐small cell lung cancer
Jiani Ye, Yinan Yao, Zhao Jianfeng, et al.
Drug Development Research (2023) Vol. 84, Iss. 2, pp. 238-252
Closed Access | Times Cited: 4
Exploiting cell death and tumor immunity in cancer therapy: challenges and future directions
Jiaan Lu, Ru He, Yang Liu, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 1
NRF3 suppresses the malignant progression of TNBC by promoting M1 polarization of macrophages via ROS/HMGB1 axis
Ping Xing, Zhenzhen Chen, Zhu Wenbo, et al.
Cancer Biology & Therapy (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 1
Strategy to Enhance Anticancer Activity and Induced Immunogenic Cell Death of Antimicrobial Peptides by Using Non-Nature Amino Acid Substitutions
Yu-Huan Cheah, Chun‐Yu Liu, Bak‐Sau Yip, et al.
Biomedicines (2022) Vol. 10, Iss. 5, pp. 1097-1097
Open Access | Times Cited: 6
Thrombospondin-1 in drug activity and tumor response to therapies
Elisa Longhi, Laura Carminati, Elena Carlessi, et al.
Seminars in Cell and Developmental Biology (2023) Vol. 155, pp. 45-51
Closed Access | Times Cited: 3
Impact of HMGB1 on cancer development and therapeutic insights focused on CNS malignancy
Sucharita Patra, Pritam Roy, Ankita Dey, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 3, pp. 189105-189105
Closed Access
Comprehensive review of drug-mediated ICD inhibition of breast cancer: mechanism, status, and prospects
Yang Wang, Rui Yang, Ying Xie, et al.
Clinical and Experimental Medicine (2024) Vol. 24, Iss. 1
Open Access
Use of drug-killed cancer cells: A method to assess the therapeutic effectiveness of immunogenic cell death
Kenny Misael Calvillo‐Rodríguez, Maria Norma Gonzalez-Flores, Reyes Támez-Guerra, et al.
Methods in cell biology (2024), pp. 211-220
Closed Access
Splenocytes antitumor cytotoxicity assessment after prophylactic vaccination or drug treatment of tumor-bearing mice
Kenny Misael Calvillo‐Rodríguez, Ana Luisa Rivera-Lazarín, Reyes Támez-Guerra, et al.
Methods in cell biology (2024), pp. 197-210
Closed Access
Page 1 - Next Page

Scroll to top